Mesirow Financial Investment Management Inc. Increases Stock Holdings in Haleon plc (NYSE:HLN)

Mesirow Financial Investment Management Inc. grew its position in Haleon plc (NYSE:HLN) by 104.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 28,112 shares of the company’s stock after buying an additional 14,349 shares during the quarter. Mesirow Financial Investment Management Inc.’s holdings in Haleon were worth $268,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. Addison Advisors LLC increased its position in Haleon by 28.7% during the 4th quarter. Addison Advisors LLC now owns 4,954 shares of the company’s stock worth $47,000 after purchasing an additional 1,106 shares in the last quarter. Synovus Financial Corp increased its position in Haleon by 0.8% during the 3rd quarter. Synovus Financial Corp now owns 148,834 shares of the company’s stock worth $1,575,000 after purchasing an additional 1,216 shares in the last quarter. Greenleaf Trust increased its position in Haleon by 8.4% during the 4th quarter. Greenleaf Trust now owns 17,225 shares of the company’s stock worth $164,000 after purchasing an additional 1,333 shares in the last quarter. Baron Wealth Management LLC increased its position in Haleon by 4.3% during the 4th quarter. Baron Wealth Management LLC now owns 33,632 shares of the company’s stock worth $321,000 after purchasing an additional 1,381 shares in the last quarter. Finally, Peapack Gladstone Financial Corp increased its position in Haleon by 3.2% during the 3rd quarter. Peapack Gladstone Financial Corp now owns 44,844 shares of the company’s stock worth $474,000 after purchasing an additional 1,390 shares in the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on HLN. Morgan Stanley lowered Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Sanford C. Bernstein lowered Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. HSBC reissued a “hold” rating on shares of Haleon in a research note on Wednesday, March 5th. Finally, Hsbc Global Res lowered Haleon from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 5th. Five research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Haleon presently has an average rating of “Moderate Buy” and a consensus price target of $10.95.

Haleon Stock Performance

NYSE HLN opened at $10.45 on Monday. The firm has a market capitalization of $47.29 billion, a P/E ratio of 30.72, a P/E/G ratio of 2.82 and a beta of 0.25. Haleon plc has a 1-year low of $7.89 and a 1-year high of $10.80. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The business’s 50-day simple moving average is $9.68 and its 200-day simple moving average is $9.86.

Haleon (NYSE:HLN) last released its quarterly earnings data on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. The business had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. Equities analysts predict that Haleon plc will post 0.43 EPS for the current year.

Haleon Increases Dividend

The business also recently declared a — dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 25th will be given a dividend of $0.1166 per share. The ex-dividend date of this dividend is Friday, April 25th. This is a positive change from Haleon’s previous — dividend of $0.05. This represents a yield of 1.6%. Haleon’s payout ratio is 58.97%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.